Fingerprint
Dive into the research topics of 'Etoposide and doxorubicin enhance the sensitivity of triple negative breast cancers through modulation of TRAIL-DR5 axis'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Etoposide and doxorubicin enhance the sensitivity of triple negative breast cancers through modulation of TRAIL-DR5 axis
Sarita Das, Neha Tripathi, Sumit Siddharth, Anmada Nayak, Deepika Nayak, Chinmayee Sethy, Prasad V. Bharatam, Chanakya Nath Kundu
Research output: Contribution to journal › Article › peer-review